Mass Spec

News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.

Dian selected the MassArray system as its platform of choice for molecular genetic testing and will commercialize it and Agena's DNA applications and products.

Based on the strong first quarter results, the company raised its revenue and earnings guidance for the year.

Enthusiasm for dried blood spot samples is building among clinical proteomic researchers and companies, but recent work suggests technical hurdles remain.

The test measures the multiple myeloma marker M protein and could prove more sensitive and less susceptible to interferences than existing assays.

They acknowledge that while the technical hurdles of proteomic test development have become manageable, commercialization is still a major challenge.